Alpha-1 antitrypsin deficiency (A1AD) is a genetic disorder that causes serious diseases including liver cirrhosis in children and adults and progressive lung disease in adults (eg COPD/emphysema/bronchiectasis). There is currently no cure or government subsided treatment in Australia. Our charity r...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2020 (6 years)
Address:
SYDNEY, AU
LOW
spending power
